Update date
31 Dec 2023
Shareable Research Card
This metric view shows EVOME MEDICAL TECHNOLOGIES INC. return on assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported return on assets: -26%. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2023
Page type
Metric history
Latest period
Q4 2023
SEC-backed company facts were refreshed from filings filed on 16 Apr 2024.
Benchmark Context
EVOME MEDICAL TECHNOLOGIES INC. sits in the upper half of the current return on assets sample.
Compared with
Compared with 9 companies reporting return on assets in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.8x the current sample midpoint. Return On Assets is up about 21% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: Q4 2023. Period end: 31 Dec 2023. Units: %. Frequency: quarterly and annual.
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Return On Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
EVOME MEDICAL TECHNOLOGIES INC. appears at rank #4 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | IMPERIAL OIL LTD (imo) | 6.7% | Quarter - 31 Mar 2026 | Open IMPERIAL OIL LTD Return On Assets |
| 2 | CANADIAN PACIFIC KANSAS CITY LTD/CN (cp) | 4.7% | Quarter - 31 Mar 2026 | Open CANADIAN PACIFIC KANSAS CITY LTD/CN Return On Assets |
| 3 | ENBRIDGE INC (enb) | 3.2% | Quarter - 31 Mar 2026 | Open ENBRIDGE INC Return On Assets |
| 4 | EVOME MEDICAL TECHNOLOGIES INC. | -26% | Year - 31 Dec 2023 | Open EVOME MEDICAL TECHNOLOGIES INC. Return On Assets |
| 5 | Canopy Growth Corp (cgc) | -33% | Quarter - 31 Dec 2025 | Open Canopy Growth Corp Return On Assets |
| 6 | Rise Gold Corp. (ryes) | -83% | Quarter - 31 Jul 2019 | Open Rise Gold Corp. Return On Assets |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2023 | -26% | +7% | +21% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -2.2% | +32% | +94% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -25% | -8.9% | -54% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -34% | -24% | -244% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -33% | -17% | -108% | 01 Sep 2022 | 30 Nov 2022 |
| Q3 2022 | -35% | 01 Jul 2022 | 30 Sep 2022 | ||
| Q2 2022 | -16% | 01 Apr 2022 | 30 Jun 2022 | ||
| Q1 2022 | -9.8% | 01 Jan 2022 | 31 Mar 2022 | ||
| Q4 2021 | -16% | 01 Sep 2021 | 30 Nov 2021 |
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2023 | -26% | 01 Jan 2023 | 31 Dec 2023 |